• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 6, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

New digital filter approach aims to improve chemical measurements

Bioengineer by Bioengineer
May 2, 2019
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Technology could help move novel drugs to clinical trials faster

WEST LAFAYETTE, Ind. – Precise measurements are critical to the discovery, development and usage of medications. Major financial and scientific decisions within pharmaceutical companies are informed by the outcomes of chemical and biological analyses. Even slight measurement variations can add risk and uncertainty in these high-stakes decisions.

A Purdue University professor and expert in measurement science has led a team to design a new filter aimed at helping drug developers and researchers create more exact measurements early in the drug development stage, which can ultimately help move a drug to clinical trials faster.

Garth Simpson, a professor of analytical and physical chemistry in Purdue’s College of Science, created the filter as part of his work with the Merck-Purdue Center for Measurement Science. The academic-industrial partnership, which started in 2017, is focused on developing technology to improve drug manufacturing and formulation to support the pharma industry in expediting drug discovery and delivery. According to the Food and Drug Administration, it can take up 10 to 15 years or longer to move a drug from discovery to the public.

The technology is published in the March 25 edition of Analytical Chemistry.

“This center provides real-world test beds for validating emerging technology related to chemical measurements,” Simpson said. “Our latest development is this novel filter design for digital deconvolution that helps us remove timing artifacts arising from the response function of the instrument we are using for data acquisition.”

Simpson said any practical measurement of an event, including those used for drug discovery, is always a combination of the event itself and the response of the measuring instrument. He said most algorithms used to correct for the response function of the instrument require a great deal of knowledge about the instrument itself.

“Our digital filter approach only requires that a user have the data,” Simpson said. “Our filter and algorithm then use non-negative matrix factorization over short sections of data to allow the analysis of data sets that are too large to be characterized by other conventional approaches.”

The filter uses mathematical formulas to analyze and organize the data, which sometimes contains millions of individual data points, into useable sets for researchers and drug developers.

Simpson said the Purdue filter can be used for measurements in microscopy, chromatography and triboluminescence, all of which are used in the early stages of drug development to determine which molecules show the greatest potential to move ahead to clinical trials.

Simpson has worked with the Purdue Office of Technology Commercialization to patent his measurement science technologies. His research team is looking for additional researchers and partners to license the technologies.

Their work aligns with Purdue’s Giant Leaps celebration, celebrating the global advancements in health and artificial intelligence as part of Purdue’s 150th anniversary. Those are two of the four themes of the yearlong celebration’s Ideas Festival, designed to showcase Purdue as an intellectual center solving real-world issues.

###

About Purdue Office of Technology Commercialization

The Purdue Office of Technology Commercialization operates one of the most comprehensive technology transfer programs among leading research universities in the U.S. Services provided by this office support the economic development initiatives of Purdue University and benefit the university’s academic activities. The office is managed by the Purdue Research Foundation, which received the 2016 Innovation and Economic Prosperity Universities Award for Innovation from the Association of Public and Land-grant Universities. For more information about funding and investment opportunities in startups based on a Purdue innovation, contact the Purdue Foundry at [email protected]. For more information on licensing a Purdue innovation, contact the Office of Technology Commercialization at [email protected]. The Purdue Research Foundation is a private, nonprofit foundation created to advance the mission of Purdue University.

Writer:Chris Adam, 765-588-3341, [email protected]

Source: Garth Simpson, [email protected]

Media Contact
Chris Adam
[email protected]
http://dx.doi.org/10.1021/acs.analchem.9b00120

Tags: BiologyChemistry/Physics/Materials SciencesMathematics/StatisticsMedicine/HealthPharmaceutical ChemistryPharmaceutical ScienceTechnology/Engineering/Computer Science
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Revolutionary ODE-VAE Enhances Single-Cell Data Clustering

September 6, 2025
Fuzzy Logic Enhances Species Distribution Model Comparison

Fuzzy Logic Enhances Species Distribution Model Comparison

September 6, 2025

Unveiling EZH2-Related lncRNAs in Gastric Cancer Insights

September 6, 2025

Silver Grunt Growth and Spawning in Okinawa Waters

September 6, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    54 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Phase II Study Finds Iza-Bren Plus Osimertinib Achieves 100% Response Rate in EGFR-Mutated NSCLC

Novel Antibody-Drug Conjugate Demonstrates Promising Efficacy in EGFR-Mutated NSCLC Patients

COMPEL Study Finds Adding Chemotherapy to Osimertinib After Progression Enhances Progression-Free Survival in EGFR-Mutated NSCLC

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.